维普期刊资源整合服务平台（V6.5）

634篇 您的检索式：作者名="Estey"

选中清除导出查看参考文献查看引证文献引用追踪共32页首页上一页第1页下一页末页 /32 跳转

	题名	作者	年代	出处	被引量
1	TEQC: The Multi-Purpose Toolkit for GPS/GLONASS Data显示文摘	Louis H. Estey Charles M. Meertens	1999	GPS Solutions1999，，1：	2
2	TEQC: The Multi-Purpose Toolkit for GPS/GLONASS Data显示文摘	Louis H. Estey Charles M. Meertens	1999	GPS Solutions1999，，1：	2
3	Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukemia and myelodysplastic syndromes显示文摘	Verstovsek S Estey E Manshouri T	2002	Br J Haematol2002，118，1：	1
4	Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European Leukemia Net显示文摘	Dohner H Estey E H Amadori S	2010	Blood2010，115，3：	1
5	Fludarabine potentiates me- tabolism of cytarabine in patients with acute myelogenous leukemia during therapy 显示文摘	Gandhi V Estey E Keating M J	2009	J Clin Oncol2009，11，：	1
6	Acute Myeloid Leukaemia显示文摘	Dr Elihu Estey Hartmut Dfihner	2006	Lancet2006，368，9550：	1
7	Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS 显示文摘	Gerds AT Gooley TA Estey EH	2012	Biol Blood Marrow Transplant2012，18，8：	1
8	TEQC : the multi-purpose toolkit for GPS/GLONASS data显示文摘	Estey L H and Meertens CM	1999	GPS Solutions1999，1，3：	1
9	Fludarabine potentiates metabolism of cytarabine in patients with acute myelogenous leukemia during therapy显示文摘	Gandhi V Estey E Keating MJ	1993	J Clin Oncol1993，11，1：	1
10	Use of Arsenic trioxide (As2O3) in the treatment of patients with acute promyelocytic leukemia显示文摘	Lazo G Kantarjian H Estey E	2003	Cancer2003，97，9：	1
11	Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte- colony- stimulating factor during therapy of acute myelogenous leukemia显示文摘	Gandhi V Estey E Du M	1995	Clin Cancer Res1995，1，2：	1
12	Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia显示文摘	Aguayo A Estey E Kantarjian H	1999	Blood1999，94，11：	1
13	Com-parison of idarubicin+ara-C,fludarabine+ara-C,andtopotecan+ara-C-based regimens in treatment ofnewly diagnosed acute myeloid leukemia,refractory a-nemia with excess blasts in transformation,or refrac-tory anemia with excess blasts显示文摘	ESTEY E H THALL P F CORTES J E	2001	Blood2001，98，：	1
14	Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myaloid leukemia 显示文摘	Aguayo A Estey E Kantarjian H	1999	Blood1999，94，11：	1
15	Treatment of newly diagnosed AML and MDS with cyclophosphamide,ara-C and topotecan 显示文摘	Estey E Kantarjian H Giles F	1998	Blood1998，，：	1
16	Plasma vascular endothelial growth factgor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome显示文摘	Aguayo A Kantarjian HM Estey EH	2002	Cancer2002，95，：	1
17	Modulation of the cellular metabolism of cytarabine and fludarabine by granulocyte-colony-stimulating factor during therapy of acute myelogenous leukemia显示文摘	Gandhi V Estey E Du M	1995	Clin Cancer Res1995，1，2：	1
18	Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts intransformatio, or acute myeloid leukemia ) on outcome of AML-type chemotherapy显示文摘	Estey E H Thall P Beran M	1997	Blood1997，90，8：	1
19	Cellular vascular growth factor is a predictor of outcome in patient with acute myeloid leukemia显示文摘	Aguayo A Estey E Kantarjian H	1999	Blood1999，94，11：	1
20	Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes 显示文摘	Aguayo A Kantarjian HM Estey EH Giles FJ Verstovsek S Manshouri T	2002	Cancer2002，95，9：	1

返回顶部每页显示：

共32页首页上一页第1页下一页末页 /32 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示